Katy Palmer is managing director of the Health Division at Escalent. She has more than 20 years of research, forecasting and consulting experience in the pharmaceutical industry. Her specialties include brand and product development using both quantitative and qualitative methods to deliver insightful, actionable results. Prior to joining Escalent in 2000, she served Eli Lilly and Company as a market research consultant on the antidepressant team within the global market research department. Katy holds a Ph.D. in infectious disease from Washington University and a bachelor's degree in biology from Lake Forest College.